Abstract
Oxidative stress has been increasingly linked to the high incidence of cardiovascular events in patients with chronic kidney disease (CKD), especially as traditional cardiovascular risk factors seem to not be able to account for the huge cardiovascular morbidity and mortality in this population group. Oxidative stress is increased in patients with renal impairment as a result of increased oxidant activity and reduced antioxidant capacity, and this is increased in a graded manner with increasing renal dysfunction. Inflammation, which is also present in CKD, further amplifies the oxidant generation process. The two clinical sequelae of oxidative stress are endothelial dysfunction and left ventricular hypertrophy, which have adverse cardiovascular consequences. With our new understanding of oxidative stress, it is now important to assess treatment options that reduce it in the hope that they reverse endothelial dysfunction and left ventricular hypertrophy and the clinical sequelae of these abnormalities. Journal of Human Hypertension (2010) 24, 1-8; doi: 10.1038/jhh.2009.70; published online 3 September 2009
Original language | English |
---|---|
Pages (from-to) | 18 |
Number of pages | 8 |
Journal | Journal of Human Hypertension |
Volume | 24 |
Issue number | 1 |
DOIs | |
Publication status | Published - Jan 2010 |
Keywords
- chronic kidney disease
- oxidative stress
- endothelial dysfunction
- left ventricular hypertrophy
- NITRIC-OXIDE SYNTHASE
- LEFT-VENTRICULAR HYPERTROPHY
- PLACEBO-CONTROLLED TRIAL
- CHRONIC-HEMODIALYSIS PATIENTS
- LONG-TERM SUPPLEMENTATION
- VITAMIN-E SUPPLEMENTATION
- CHRONIC KIDNEY-DISEASE
- APOE-DEFICIENT MICE
- CARDIOVASCULAR-DISEASE
- SUPEROXIDE-DISMUTASE